首页 / 技术领域 / 有蹄类动物 / 专利数据
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
161 Determining immunoglobulins in non-blood body fluids of neonatal ungulates US14093574 2013-12-02 US09012157B2 2015-04-21 Nathan L. Smith
Provided is a method for determining immunoglobulins in a neonatal ungulate. The method entails obtaining a sample of oral secretions from the neonatal ungulate and measuring an amount of immunoglobulins in the sample of oral secretions. The method is faster and more convenient than previously available methods for determining immunglobulins in neonatal ungulates, such as neonatal horses and cattle.
162 Antibodies specific for ungulate PrP US10355780 2003-01-30 US07094553B2 2006-08-22 Stanley B. Prusiner; Jiri G. Safar; R. Anthony Williamson; Dennis R. Burton
The present invention provides antibodies that specifically bind with a high degree of binding affinity to a native ungulate PrPC and/or a denatured ungulate PrPSc, but not to a native ungulate PrPSc. Preferred antibodies find native bovine PrPC and treated PrPSc but not native bovine PrPSc and can be used in an assay to determine if a sample is infected with infectious prions, i.e. PrPSc.
163 DETERMINING IMMUNOGLOBULINS IN NON-BLOOD BODY FLUIDS OF NEONATAL UNGULATES US14093574 2013-12-02 US20140086902A1 2014-03-27 Nathan L. Smith
Provided is a method for determining immunoglobulins in a neonatal ungulate. The method entails obtaining a sample of oral secretions from the neonatal ungulate and measuring an amount of immunoglobulins in the sample of oral secretions. The method is faster and more convenient than previously available methods for determining immunglobulins in neonatal ungulates, such as neonatal horses and cattle.
164 Determining Immunoglobulins In Non-Blood Body Fluids Of Neonatal Ungulates US12610649 2009-11-02 US20100111934A1 2010-05-06 Nathan L. Smith
Provided is a method for determining immunoglobulins in a neonatal ungulate. The method entails obtaining a sample of oral secretions from the neonatal ungulate and measuring an amount of immunoglobulins in the sample of oral secretions. The method is faster and more convenient than previously available methods for determining immunglobulins in neonatal ungulates, such as neonatal horses and cattle.
165 Cleaning water for ungulate and cleaning of ungulate by using the same water JP19392899 1999-07-08 JP2001017016A 2001-01-23 ACHINAMI NOBUO; MIYAJI MASATO
PROBLEM TO BE SOLVED: To obtain a cleaning water for an ungulate, having a bactericidal effect and bacteria-eradicating effect, increasing the preventing and treating effect toward a hoof disease and useful for the horse, cow, pig, etc., by using electrolytically produced water obtained by using a dilute aqueous solution of a chloride as the water to be electrolyzed. SOLUTION: This cleaning water is electrolytically produced water by using a dilute aqueous solution of a chloride such as table salt as the water to be electrolyzed. Further, the cleaning water for ungulate is an acid water produced at a cathode chamber 22b by an electrolysis using a diaphragm, or an alkaline water produced by an anode chamber 22a, and is preferable that it is a cleaning water for cleaning lower limbs of the ungulate, also for a preliminary cleaning, a first cleaning vessel 11 for storing the alkaline water is used, and for a post cleaning, a second cleaning vessel 12 for storing the acid water is used. It is preferable to clean the ungulate by passing the ungulate to be cleaned through the first cleaning vessel 11 and then passing through the second cleaning vessel 12. COPYRIGHT: (C)2001,JPO
166 ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS EP04777430.2 2004-07-02 EP1638598A2 2006-03-29 BRIGGS, Robert, E.; TATUM, Fred, M.
A capsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry.
167 Grazing method for controlling and/or eradicating noxious plants including invasive plant species US11304476 2005-12-14 US07536979B2 2009-05-26 Mark A. Robbins
The present invention is a method of controlling noxious plant species. The method comprises identifying a target area in a foraging area, selecting a treatment period, selecting an ungulate specie, providing an animal feed supplement at a first deployment location in the target area, and introducing the selected ungulate specie to the animal feed supplement in the target area during the treatment period. The target is considered such because it includes a noxious plant specie. During the treatment period, the selected ungulate specie will interact with the noxious plant specie in the target area. For example, the ungulates interact with the noxious plant specie by eating the noxious plant specie and/or by trampling the noxious plant specie. The animal feed supplement is highly-palatable, portable, self-limiting, attracts the ungulate specie to the target area, and increases the length of stay of the ungulate specie in the target area.
168 LYSOZYME TRANSGENIC UNGULATES PCT/US2004000606 2004-01-08 WO2004063349A3 2004-11-11 MURRAY JAMES D; ANDERSON GARY B; MAGA ELIZABETH A
The present invention provides transgenic ungulates that include a transgene that encodes lysozyme, and further has an attenuated or non-functional beta-lactoglobulin allele. The invention further provides methods for producing such animals. The invention further provides methods of producing a food product, such as milk, or a milk product, using a subject transgenic ungulate, as well as food products harvested from a subject transgenic ungulate.
169 Antibodies specific for ungulate PrP US09627218 2000-07-27 US06537548B1 2003-03-25 Stanley B. Prusiner; Jiri Safar; R. Anthony Williamson; Dennis R. Burton
The present invention provides antibodies that specifically bind with a high degree of binding affinity to a native ungulate PrPC and/or a denatured ungulate PrPSc, but not to a native ungulate PrPSc. Preferred antibodies find native bovine PrPC and treated PrPSc but not native bovine PrPSc and can be used in an assay to determine if a sample is infected with infectious prions, i.e. PrPSc.
170 Diagnostic, Therapeutic And A Vaccine Against Treponemes US13433258 2012-03-28 US20120251578A1 2012-10-04 Hank (Henry) Michael Lefler
The development of a diagnostic, therapeutic and making and administering a vaccine against ungulate diseases which involves spirochete bacteria in particular, Treponemes.
171 Diagnostic, therapeutic and a vaccine against treponemes US13433258 2012-03-28 US09364526B2 2016-06-14 Hank (Henry) Michael Lefler
The development of a diagnostic, therapeutic and making and administering a vaccine against ungulate diseases which involves spirochete bacteria in particular, Treponemes.
172 POWDER COMPOSITION FOR THE DISINFECTION OF UNGULATES' BATHS PCT/EP2012/074464 2012-12-05 WO2013083612A1 2013-06-13 GELMI, Fabio; VENTURINI, Maurizio

A powder composition for the disinfection of ungulates' baths is disclosed. In particular the present invention relates to the use of a powder composition as a disinfecting agent for the preparation of the baths suitable for ungulates' prophylaxis. It comprises at least one chlorinated organic compound, copper sulphate, EDTA, a natural gum and an inorganic carbonate at specific weight percentages.

173 Preconditioning a wildlife foraging area US10626293 2003-07-24 US20050081792A1 2005-04-21 Mark Robbins
The present invention, in one embodiment, is a method of using a plurality of domestic ungulates to precondition a foraging area to enhance the attractiveness of the foraging area to a plurality of wild ungulates. The method comprises selecting the foraging area to be preconditioned, selecting a target period, selecting a preconditioning period, and providing at least one highly palatable, portable, self-limiting, animal feed supplement in the foraging area during the preconditioning period. The target period is when the plurality of wild ungulates uses the foraging area once it has been preconditioned. The preconditioning period is when the plurality of domesticated ungulates preconditions (i.e., forages) the foraging area for use by the wild ungulates during the target period. The highly palatable, portable, self-limiting, animal feed supplement attracts the plurality of domesticated ungulates to the foraging area and increases the length of stay of the plurality of domesticated ungulates in the foraging area.
174 프리온 단백질 활성이 감소된 트랜스제닉 유제동물 및 그의용도 KR1020057008140 2003-11-10 KR1020050093761A 2005-09-23 로블,제임스; 구로이와,요시미; 도미즈까,가즈마; 이시다,이사오
The invention provides cloned transgenic ungulates (e.g., bovines) in which prion protein activity is reduced by one or more genetically engineered mutations. Desirably, these transgenic bovines are also genetically modified to express xenogenous (e.g., human) antibodies. Because of their resistance to prion-related diseases such as bovine spongiform encephalopy (also known as mad cow disease), these bovines are a safer source of human antibodies for pharmaceutical uses and safer source of agricultural products.
175 ANIMAL REPELLING DEICER PCT/US2011/056698 2011-10-18 WO2013058738A1 2013-04-25 ROSENBURGH, Neil Alexander; DAUM, Michelle Lee; BAGLEY, Jason Louis; PANNELL, Dan; SHELITE, Kristopher

Deicing products designed to deter ungulates are provided, along with methods of using those products to treat iced surfaces. The deicing product comprises a mixture of a deicer along with an ungulate repellent. The repellent can repel based on conditioned avoidance, fear, chemical irritation, and/or bad taste. The deicer can be a salt or a deicer solution. The invention is useful for deterring any ungulate that might be attracted to a component of the deicing product (e.g., the salt), but it is particularly useful for deterring deer.

176 免疫組合物及方法 COMPOSITION AND METHOD FOR IMMUNIZATION TW097120955 2008-06-05 TW200918552A 2009-05-01 格蘭 湯瑪斯 瑞林 RAWLIN, GRANT THOMAS; 洛伊 邁可 羅冰斯 布朗 ROBINS-BROWNE, ROY MICHAEL; 希爾 羅森布格 ROSENBERG, ZEIL
本發明係有關一種包含多株抗體且用於個體被動免疫對抗EV71之口服製劑組合物;及一種於超免疫有類動物之初乳或者超免疫禽類蛋中產生對抗EV71抗原之多株抗體之方法。
177 VACCINE AGAINST PAPILLOMATOUS DIGITAL DERMATITIS (PDD) PCT/US1999/026537 1999-11-09 WO00027429A2 2000-05-18
This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins.
178 Vaccines comprising acapsular P. multocida hyaE deletion mutants US10882666 2004-07-02 US20050106185A1 2005-05-19 Robert Briggs; Fred Tatum
Acapsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry.
179 Vaccines comprising acapsular P. multocida hyaE deletion mutants US10882666 2004-07-02 US07351416B2 2008-04-01 Robert E. Briggs; Fred M. Tatum
Acapsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry.
180 EMBRYONIC STEM CELLS FOR MAKING CHIMERIC AND TRANSGENIC UNGULATES PCT/US1994005529 1994-05-16 WO1994026884A1 1994-11-24 BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION; WHEELER, Matthew, B.
Transgenic ungulates and compositions and methods for making and using same, are provided. Central to the invention are porcine, bovine, ovine and caprine embryonic stem cell lines and methods for establishing them. Cells of such lines are transformed with exogenous genetic material of interest and then used to provide chimeric ungulates which have germ cells comprising the exogenous genetic material. The chimeric ungulates are bred to provide transgenic ungulates. The transgenic animals of the invention may show improved qualities and can be used to provide human proteins or peptide hormones or can be used as xenograft donors.
QQ群二维码
意见反馈